Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 10OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

tislelizumab 12Capecitabine 8apatinib 5Surgical Procedures, Operative 5Carboplatin 5Oxaliplatin 4Drug Therapy 4Cisplatin 4Radiation 3Paclitaxel 3Immunotherapy 3Bevacizumab 3toripalimab 2anlotinib 2Standard of Care 2Radiotherapy 2Methods 2Melphalan 2Low-Level Light Therapy 2Letrozole 2Interleukin-2 2Injections 2Cryotherapy 2130-nm albumin-bound paclitaxel 2zanubrutinib 1trastuzumab deruxtecan 1sintilimab 1pyrotinib 1pertuzumab 1obinutuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Saline Solution × Clear all
NCT07125924 2025-08-15

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

National Cancer Center, Korea

Phase NA Not yet recruiting
54 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡